Intrinsiqq

Gentian Diagnostics ASA (GENT.XOSL) Dividend Analysis

Does Gentian Diagnostics ASA (GENT.XOSL) pay a dividend?

Yes. Gentian Diagnostics ASA (GENT.XOSL) pays a dividend: NOK 0.60 per share over the last twelve months, a dividend yield of 1.63% at the latest close.

It has raised its dividend per share for at least 1 year in a row (every year of the history we hold). The payout takes about 69.8% of earnings.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025NOK 0.60+50.0%
2024NOK 0.40

All 2 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

GENT.XOSL
Dividend39
Dividend payer

no sustained growth pattern yet.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

18

Safety

40% of composite

Earnings Payout0
N/ANot reported
FCF Coverage35
1.4xThin margin
60

Growth

35% of composite

Dividend Streak20
1+YNo sustained streak
Growth Rate100
50.0%Strong compounder
45

Income

25% of composite

Cash Yield (TTM)45
1.63%Below average

Composite = Safety (18) × 0.40 + Growth (60) × 0.35 + Income (45) × 0.25 = 39

Dividend Yield

1.63%

Per Share (TTM)

NOK 0.60

Payout Ratio

69.8%

1Y CAGR

50.0%

Dividend Safety

Earnings Payout

69.8%

FCF Payout

71.9%

FCF Coverage

1.4x

Dividend Growth

Per Share (TTM)

NOK 0.60

Growth Streak

1+ year

1Y CAGR

50.0%

Dividend Income

Annual DPS (TTM)

NOK 0.60

Annual Income / €10K

€163

Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.

Yield History

Gentian Diagnostics ASA (GENT.XOSL) dividend: yield, safety and growth

Frequently asked

Does Gentian Diagnostics ASA (GENT.XOSL) pay a dividend, and how much?+

Yes, Gentian Diagnostics ASA pays a regular dividend of about NOK 0.60 per share per year (a yield of roughly 1.6%). That is a payout ratio of about 69.8% of earnings, so it is covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.

Is Gentian Diagnostics ASA's dividend safe?+

Gentian Diagnostics ASA's dividend looks covered by free cash flow, with free cash flow covering the payout about 1.4 times over. Intrinsiqq scores its dividend safety at 43 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.

Has Gentian Diagnostics ASA grown its dividend?+

Gentian Diagnostics ASA has raised its dividend for at least 1 year in a row, the full span of the dividend history we hold. Over the past five years the dividend has grown at roughly 50.0% a year. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.

What is Gentian Diagnostics ASA's dividend payout ratio?+

Gentian Diagnostics ASA pays out about 69.8% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.

Related stocks: Medical Devices

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.